Table 2.

Characteristics of the GISTs that changed in size

No.	Sex	Age	Site	Initial Size	F/u Size	Initial EUS	F/u EUS	Treatment	Final Diagnosis	Mitotic count	Mutation type
1	M	72	Fundus	6	17	Low risk	Low risk	OP	GIST	7/50HPF	KIT exon 11
2	F	75	Body	16	30	Low risk	High risk	OP	GIST	6/50HPF	KIT exon 11
3	M	71	Body	20	40	Low risk	High risk	OP	GIST	10/50HPF	KIT exon 11
4	F	51	Fundus	8	15	Low risk	High risk	OP	GIST	0/50HPF	KIT exon 11
5	F	83	Fundus	7	15	Low risk	Low risk	Surveillance	Not available	Not available	Not available
6	F	78	Body	11	22	Low risk	High risk	OP	GIST	2/50HPF	KIT exon 11
7	M	67	Body	12	17	Low risk	Low risk	OP	GIST	3/50HPF	KIT exon 11
8	M	57	Fundus	10	12	Low risk	Low risk	Surveillance	Not available	Not available	Not available
9	F	51	Fundus	10	13	Low risk	Low risk	Surveillance	Not available	Not available	Not available
10	F	53	Body	11	15	Low risk	Low risk	Surveillance	Not available	Not available	Not available
11	M	84	Body	18	35	Low risk	High risk	OP	GIST	3/50HPF	KIT exon 11
12	F	57	Body	11	14	Low risk	Low risk	Surveillance	Not available	Not available	Not available
13	M	67	Body	15	30	Low risk	Low risk	OP	GIST	6/50HPF	KIT exon 11
14	M	65	Fundus	10	24	Low risk	High risk	OP	GIST	3/50HPF	KIT exon 11
15	F	59	Body	12	15	Low risk	Low risk	OP	GIST	0/50HPF	KIT exon 11
16	F	51	Fundus	8	13	High risk	High risk	OP	GIST	2/50HPF	Wild-type

Abbreviations: F/u indicates follow-up, HR high risk, IR intermediate risk, LR low risk, OP operation